State Street Corp Boosts Holdings in Owens & Minor, Inc. (NYSE:OMI)

State Street Corp grew its holdings in Owens & Minor, Inc. (NYSE:OMI - Free Report) by 2.6% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 3,064,547 shares of the company's stock after purchasing an additional 78,985 shares during the quarter. State Street Corp owned approximately 3.97% of Owens & Minor worth $48,083,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of OMI. Royce & Associates LP lifted its stake in shares of Owens & Minor by 179.4% during the 3rd quarter. Royce & Associates LP now owns 80,914 shares of the company's stock worth $1,270,000 after purchasing an additional 51,955 shares during the last quarter. Deerfield Management Company L.P. Series C lifted its position in shares of Owens & Minor by 30.6% during the second quarter. Deerfield Management Company L.P. Series C now owns 6,371,440 shares of the company's stock valued at $86,014,000 after buying an additional 1,493,852 shares during the last quarter. Renaissance Technologies LLC boosted its holdings in shares of Owens & Minor by 16.5% in the 2nd quarter. Renaissance Technologies LLC now owns 1,246,600 shares of the company's stock valued at $16,829,000 after buying an additional 176,250 shares in the last quarter. Dimensional Fund Advisors LP grew its position in shares of Owens & Minor by 1.7% in the 2nd quarter. Dimensional Fund Advisors LP now owns 4,534,204 shares of the company's stock worth $61,213,000 after buying an additional 76,599 shares during the last quarter. Finally, FMR LLC raised its stake in shares of Owens & Minor by 0.8% during the 3rd quarter. FMR LLC now owns 11,564,624 shares of the company's stock worth $181,449,000 after acquiring an additional 90,862 shares in the last quarter. Institutional investors own 98.04% of the company's stock.

Analyst Upgrades and Downgrades

Several research firms have issued reports on OMI. Robert W. Baird cut their price target on shares of Owens & Minor from $19.00 to $14.00 and set a "neutral" rating on the stock in a report on Tuesday, November 5th. StockNews.com lowered Owens & Minor from a "buy" rating to a "hold" rating in a research report on Monday, August 26th. UBS Group lowered their price target on Owens & Minor from $28.00 to $25.00 and set a "buy" rating for the company in a report on Tuesday, November 5th. Barclays cut their price objective on shares of Owens & Minor from $18.00 to $14.00 and set an "equal weight" rating on the stock in a report on Tuesday, November 5th. Finally, Citigroup decreased their price objective on shares of Owens & Minor from $21.00 to $18.50 and set a "buy" rating for the company in a research report on Tuesday, November 5th. Two research analysts have rated the stock with a sell rating, five have given a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of "Hold" and an average price target of $18.50.

Owens & Minor Stock Performance

NYSE:OMI traded down $0.10 during midday trading on Friday, hitting $12.52. The company's stock had a trading volume of 2,813,476 shares, compared to its average volume of 810,074. Owens & Minor, Inc. has a fifty-two week low of $11.42 and a fifty-two week high of $28.35. The company has a debt-to-equity ratio of 2.11, a current ratio of 1.09 and a quick ratio of 0.45. The firm has a market cap of $965.40 million, a P/E ratio of -19.26, a P/E/G ratio of 0.48 and a beta of 0.42. The firm's 50 day moving average is $13.28 and its 200-day moving average is $14.62.

Owens & Minor (NYSE:OMI - Get Free Report) last released its quarterly earnings data on Monday, November 4th. The company reported $0.42 earnings per share for the quarter, topping analysts' consensus estimates of $0.41 by $0.01. The firm had revenue of $2.72 billion for the quarter, compared to analyst estimates of $2.68 billion. Owens & Minor had a negative net margin of 0.46% and a positive return on equity of 14.60%. The business's quarterly revenue was up 5.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.44 earnings per share. Equities analysts anticipate that Owens & Minor, Inc. will post 1.49 earnings per share for the current fiscal year.

Insider Buying and Selling at Owens & Minor

In related news, CFO Jonathan A. Leon sold 5,282 shares of the business's stock in a transaction on Thursday, November 21st. The shares were sold at an average price of $11.82, for a total value of $62,433.24. Following the completion of the transaction, the chief financial officer now directly owns 130,822 shares in the company, valued at $1,546,316.04. The trade was a 3.88 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 2.62% of the company's stock.

About Owens & Minor

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.